Review
Oct 2026
Pembrolizumab-Induced Sarcoidosis-Like Immune-Related Adverse Events: A Pooled Analysis of Published Cases and Report of a Novel Manifestation Involving Phosphocalcic Metabolism.
Pembrolizumab-induced DISR is a rare irAE driven by immune dysregulation, and this case expands its clinical spectrum by identifying a novel manifestation of macrophage-mediated calcium dysregulation.
Coral Arévalo-Cañas, José Zamoro-Lorenci M, Laura Pérez-Ibáñez et al.
· Journal of immunotherapy · 0 citations